Avecho Biotechnology Ltd

AVE

Company Profile

  • Business description

    Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches, including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.

  • Contact

    Unit A8, 2A Westall Road
    Clayton
    MelbourneVIC3168
    AUS

    T: +61 390025000

    https://www.avecho.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    34

Stocks News & Analysis

stocks

Investors cheer Guzman dialing back global ambitions

Our view after US restaurants are closed.
stocks

Why stocks sometimes fall for no obvious reason

How the private markets impact all equity investors.
stocks

Poor organic growth obscured by acquisition for ASX listed share

Sales dropped by 2% without impact of acquisition.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,882.6020.50-0.23%
CAC 408,188.1870.08-0.85%
DAX 4025,223.76165.34-0.65%
Dow JONES (US)50,525.1554.55-0.11%
FTSE 10010,512.2345.970.44%
HKSE25,599.456.58-0.03%
NASDAQ26,687.83343.861.31%
Nikkei 22564,996.09162.10-0.25%
NZX 50 Index13,069.7499.460.77%
S&P 5007,533.1559.680.80%
S&P/ASX 2008,657.8018.80-0.22%
SSE Composite Index4,145.377.20-0.17%

Market Movers